======= CR2 ======= == Gene Information == * **Official Symbol**: CR2 * **Official Name**: complement C3d receptor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1380|1380]] * **UniProt**: [[https://www.uniprot.org/uniprot/P20023|P20023]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CR2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CR2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/120650|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]. * **UniProt Summary**: Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRNPU (PubMed:7753047). Participates in B lymphocytes activation (PubMed:7753047). {ECO:0000269|PubMed:7753047}. |Sushi| |complement receptor activity| |complement binding| |complement receptor mediated signaling pathway| |B cell proliferation| |virus receptor activity| |lymphocyte proliferation| |mononuclear cell proliferation| |viral entry into host cell| |leukocyte proliferation| |entry into host| |entry into host cell| |B cell differentiation| |regulation of complement activation| |transmembrane signaling receptor activity| |regulation of humoral immune response| |B cell activation| |interaction with host| |complement activation, classical pathway| |humoral immune response mediated by circulating immunoglobulin| |complement activation| |viral life cycle| |receptor complex| |immunoglobulin mediated immune response| |B cell mediated immunity| |lymphocyte differentiation| |lymphocyte mediated immunity| |adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |leukocyte differentiation| |humoral immune response| |lymphocyte activation| |immune response-activating cell surface receptor signaling pathway| |regulation of immune effector process| |immune response-regulating cell surface receptor signaling pathway| |cell population proliferation| |hemopoiesis| |immune response-activating signal transduction| |immune response-regulating signaling pathway| |hematopoietic or lymphoid organ development| |adaptive immune response| |activation of immune response| |immune system development| |viral process| |leukocyte mediated immunity| |innate immune response| |symbiotic process| |interspecies interaction between organisms| |positive regulation of immune response| |protein homodimerization activity| |leukocyte activation| |defense response to other organism| |cell activation| |immune effector process| |positive regulation of immune system process| |regulation of immune response| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |DNA binding| |regulation of immune system process| |immune response| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|1.77| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12481 * **Expression level (log2 read counts)**: 0.3 {{:chemogenomics:nalm6 dist.png?nolink |}}